This session will provide a practical overview of dermatologic toxicities associated with oncology therapies, equipping clinicians with the knowledge and tools to optimize patient care. Participants will learn to recognize common and clinically significant skin-related adverse effects linked to various anticancer agents, including targeted therapies, immunotherapies, and traditional chemotherapy. The session will explore the prevalence, underlying mechanisms, and standardized grading of these toxicities to support accurate assessment and clinical decision-making. Emphasis will also be placed on evidence-based management strategies, including prevention, early intervention, and treatment approaches, to minimize treatment interruptions and improve patient outcomes and quality of life.

Learning Objectives:

• Identify dermatologic toxicities of various oncology agents
• Describe the prevalence, grading, and mechanisms of these toxicities
• Explain the management of dermatologic toxicities in patients when they appear

Pending CCCEP Accreditation for 1 CEU